
Single-Cell Analysis of T Cells Helps Predict Disease Risk
December 6, 2022 2:48 pm Leave your thoughtsIn a recent publication [1], a collaborative research group based in La Jolla, CA cite using Excellos sourced T cells... View Article
In a recent publication [1], a collaborative research group based in La Jolla, CA cite using Excellos sourced T cells... View Article
Scientists at the University of Florida College of Medicine report that natural variability in donor stem cells can have a... View Article
Researchers at the La Jolla Institute for Immunology cite using Excellos sourced healthy donor starting material to carry out single-cell... View Article
A case of immune T-cell identity theft gave German scientists the vital clue they needed to understand a key mechanism... View Article
Scientists at Scripps Research Center in La Jolla are working to streamline monoclonal antibody vaccine development by devising more efficient... View Article
Researchers at UCSD and Memorial Sloan Kettering Cancer Center used Excellos healthy donor starting material to carry out a fascinating... View Article
NK cell therapy holds the promise of new therapeutics for underserved cancer indications. A recent publication in Nature Communications uses... View Article
A new Allogeneic CAR-T study has shown CAR-T cells derived from healthy donors to be superior at fighting cancer compared... View Article
Where the Cell Therapy industry is facing an ever-growing complexity in supply chain and logistics, now is the time to... View Article
Raw material experts Dr. David Wellis and Dr. Robert Tressler want to share their knowledge on how to select and... View Article